Carregant...
Modern Obesity Pharmacotherapy: Weighing Cardiovascular Risk and Benefit
Obesity is a major correlate of cardiovascular disease. Weight loss improves cardiovascular risk factors and has the potential to improve outcomes. Two drugs, phentermine plus topiramate and lorcaserin, have recently been approved by the US Food and Drug Administration for the indication of obesity;...
Guardat en:
| Publicat a: | Clin Cardiol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley Periodicals, Inc.
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649490/ https://ncbi.nlm.nih.gov/pubmed/25223901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22304 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|